John W. Day

Scientific Advisor at PepGen

Dr. Day is a Professor of Neurology, Pediatrics (Genetics) and Pathology and Director of the Division of Neuromuscular Medicine at Stanford University. Throughout his career, Dr. Day has investigated the multisystemic effects of myotonic dystrophy type 1 and 2 and other genetic disorders and has more than 30 years of experience directing clinical trials of oligonucleotide and other novel treatments that correct genetic disorders of nerves and muscles. He is an advisor for multiple organizations in the neuromuscular disease space, including the National Advisory Committee for the Myotonic Dystrophy Foundation, and is a member of the Society for Neuroscience, the American Academy of Neurology, and the World Muscle Society, among others. Dr. Day received his M.D. from the University of Minnesota and earned his Ph.D. in neuroscience from the Albert Einstein College of Medicine, where he studied synaptic physiology and plasticity.


Timeline

  • Scientific Advisor

    Current role